SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Lidak Pharm. [LDAKA]

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: John Zwiener who wrote (210)5/9/1997 9:58:00 PM
From: luis a. garcia   of 1115
 
John they are in phase two of testing for this very thing. That is beyond the theoretical/design/and discovery and preclinical test phase.. You would think they would not be easily fooled by false positives and charge into a medical conference with wing and a prayer... You rub this thing on and hey! improvement...that's all any way its going in the right direction..

LIDAKOL is in phase 3 oral herpes.. and Genital Herpes. dual test due July 97 In phase 2 for Kaposi's Sarcoma, Molluscum Contagiosum,

In phase 1.5 for Shingles
In preclinical 1 for Hiv Prevention (during intercourse)

AS AN ANTI-INFLAMATORY INDICATOR

phase 1.5 for Hypertropic scarring, burns, wound healing

R&D for ophtalmic indicator, anti-fungal indications, systemic
anti viral

Then the company has LMI (Large Multivalent Immunogen)

Cancer Indications------phase 2 Melanoma

R&D Anti viral indicator, Ige receptor modulation, dendritic cell based vaccines, stem cell proliferation..

anyhow the stock appears poised to go higher in the
next 3 months...

luis
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext